<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT942-7750</title>
	</head>
	<body>
		<main>
			<p>940524 FT  24 MAY 94 / UK Company News: British Biotech British Biotechnology has moved its main product, the cancer treatment Batimastat, into the next stage of clinical development. Success with the first trials, announced in March, led within two weeks to a Pounds 94m cash-raising exercise. The next stage - Phase 2 - is designed to determine the best doses. Phase 3 ' large scale trials ' is scheduled to start in the last quarter of 1994. If the trials are successful, the product could be launched in 1996 or 1997.</p>
		</main>
</body></html>
            